Added to YB: 2021-01-21
Pitch date: 2021-01-21
ONCT [bullish]
Oncternal Therapeutics, Inc.
-99.53%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs.
Market Cap
$1.6M
Pitch Price
$112.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.37
P/E
-0.05
EV/Sales
-5.94
Sector
Biotechnology
Category
N/A
Show full summary:
ONCTERNAL THERAPEUTICS INC ONCT
A summary for this pitch has not been created yet.
Read full article (0 min)